ERIS Lifescience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,319.50
-8.4 (-0.63%)
BSENSE

Nov 20

BSE+NSE Vol: 35.84 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
892.37
873.25
756.56
807.45
792.41
773.00
705.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
892.37
873.25
756.56
807.45
792.41
773.00
705.30
Raw Material Cost
107.86
94.27
68.12
105.85
82.58
70.10
68.28
Purchase of Finished goods
167.72
131.12
122.97
117.24
146.09
104.26
95.98
(Increase) / Decrease In Stocks
-49.85
13.86
-5.84
0.21
-26.26
10.28
5.99
Employee Cost
149.19
153.42
136.85
138.08
137.45
144.43
121.45
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
208.10
184.36
160.89
164.46
164.34
167.22
161.21
Total Expenditure (Excl Depreciation)
583.02
577.03
482.99
525.84
504.20
496.29
452.91
Operating Profit (PBDIT) excl Other Income
309.35
296.22
273.57
281.61
288.21
276.71
252.39
Other Income
3.20
2.39
2.23
0.02
2.81
2.69
7.95
Operating Profit (PBDIT)
312.55
298.61
275.80
281.63
291.02
279.40
260.34
Interest
46.42
46.65
45.62
48.82
49.55
48.68
54.28
Exceptional Items
-35.90
0.00
0.00
-17.24
0.00
0.00
0.00
Gross Profit (PBDT)
230.23
251.96
230.18
215.57
241.47
230.72
206.06
Depreciation
73.42
72.07
69.57
70.34
69.08
70.51
77.25
Profit Before Tax
155.91
179.49
159.41
145.35
172.67
161.10
128.87
Tax
-31.23
36.17
-119.69
36.52
38.20
36.00
26.52
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
188.04
143.72
280.30
108.71
134.19
124.21
102.29
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
188.04
143.72
280.30
108.71
134.19
124.21
102.29
Share in Profit of Associates
-0.90
-0.40
-1.20
0.12
0.28
0.89
0.06
Minority Interest
3.32
0.93
-2.51
9.11
14.28
7.11
8.51
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
183.82
142.39
281.61
99.72
120.19
117.99
93.84
Equity Capital
13.87
13.86
13.85
13.61
13.62
13.62
13.62
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
3,077.54
0.00
0.00
Earnings per share (EPS)
13.25
10.27
20.33
7.33
8.82
8.66
6.89
Diluted Earnings per share
13.25
10.26
20.57
7.31
8.81
8.64
6.89
Operating Profit Margin (Excl OI)
34.78%
34.09%
36.36%
35.16%
36.48%
35.86%
35.92%
Gross Profit Margin
25.88%
28.99%
30.6%
26.92%
30.56%
29.9%
29.33%
PAT Margin
21.04%
16.49%
37.1%
13.59%
17.02%
16.21%
14.57%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2026 is 12.61% vs 6.91% in Sep 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2026 is 52.94% vs 31.23% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2026 is 7.33% vs 8.96% in Sep 2025

stock-summary

Interest

YoY Growth in quarter ended Sep 2026 is -6.32% vs -16.68% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025

Compare Quarterly Results Of ERIS Lifescience With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
892.37
2,603.48
-1,711.11
-65.72%
Other Operating Income
0.00
0.00
0.00
Total Operating income
892.37
2,603.48
-1,711.11
-65.72%
Raw Material Cost
107.86
599.64
-491.78
-82.01%
Purchase of Finished goods
167.72
177.22
-9.50
-5.36%
(Increase) / Decrease In Stocks
-49.85
-91.09
41.24
45.27%
Employee Cost
149.19
503.75
-354.56
-70.38%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
208.10
850.69
-642.59
-75.54%
Total Expenditure (Excl Depreciation)
583.02
2,040.21
-1,457.19
-71.42%
Operating Profit (PBDIT) excl Other Income
309.35
563.27
-253.92
-45.08%
Other Income
3.20
15.11
-11.91
-78.82%
Operating Profit (PBDIT)
312.55
578.38
-265.83
-45.96%
Interest
46.42
38.26
8.16
21.33%
Exceptional Items
-35.90
0.00
-35.90
Gross Profit (PBDT)
230.23
540.12
-309.89
-57.37%
Depreciation
73.42
100.80
-27.38
-27.16%
Profit Before Tax
155.91
437.95
-282.04
-64.40%
Tax
-31.23
104.05
-135.28
-130.01%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
188.04
335.27
-147.23
-43.91%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
188.04
335.27
-147.23
-43.91%
Share in Profit of Associates
-0.90
-1.37
0.47
34.31%
Minority Interest
3.32
-1.27
4.59
361.42%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
183.82
335.17
-151.35
-45.16%
Equity Capital
13.87
39.31
-25.44
-64.72%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
13.25
17.05
-3.80
-22.29%
Diluted Earnings per share
13.25
17.05
-3.80
-22.29%
Operating Profit Margin (Excl OI)
34.78%
21.64%
0.00
13.14%
Gross Profit Margin
25.88%
20.75%
0.00
5.13%
PAT Margin
21.04%
12.83%
0.00
8.21%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 892.37 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 2.19% vs 15.42% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 12.61% vs 6.91% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 183.82 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 29.10% vs -49.44% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 52.94% vs 31.23% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 309.35 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 4.43% vs 8.28% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 7.33% vs 8.96% in Sep 2025

Quarterly - Interest
Interest 46.42 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -0.49% vs 2.26% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -6.32% vs -16.68% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 34.78%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025